180 related articles for article (PubMed ID: 28636974)
1. SEMA3A partially reverses VEGF effects through binding to neuropilin-1.
Palodetto B; da Silva Santos Duarte A; Rodrigues Lopes M; Adolfo Corrocher F; Roversi FM; Soares Niemann F; Priscila Vieira Ferro K; Leda Figueiredo Longhini A; Melo Campos P; Favaro P; Teresinha Olalla Saad S
Stem Cell Res; 2017 Jul; 22():70-78. PubMed ID: 28636974
[TBL] [Abstract][Full Text] [Related]
2. Association of axon guidance factor semaphorin 3A with poor outcome in pancreatic cancer.
Müller MW; Giese NA; Swiercz JM; Ceyhan GO; Esposito I; Hinz U; Büchler P; Giese T; Büchler MW; Offermanns S; Friess H
Int J Cancer; 2007 Dec; 121(11):2421-33. PubMed ID: 17631638
[TBL] [Abstract][Full Text] [Related]
3. Neuropilin ligands in vascular and neuronal patterning.
Fantin A; Maden CH; Ruhrberg C
Biochem Soc Trans; 2009 Dec; 37(Pt 6):1228-32. PubMed ID: 19909252
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival.
Corradi G; Baldazzi C; Očadlíková D; Marconi G; Parisi S; Testoni N; Finelli C; Cavo M; Curti A; Ciciarello M
Stem Cell Res Ther; 2018 Oct; 9(1):271. PubMed ID: 30359303
[TBL] [Abstract][Full Text] [Related]
5. CXCL12+ stromal cells as bone marrow niche for CD34+ hematopoietic cells and their association with disease progression in myelodysplastic syndromes.
Abe-Suzuki S; Kurata M; Abe S; Onishi I; Kirimura S; Nashimoto M; Murayama T; Hidaka M; Kitagawa M
Lab Invest; 2014 Nov; 94(11):1212-23. PubMed ID: 25199050
[TBL] [Abstract][Full Text] [Related]
6. Neuropilin 1 regulates bone marrow vascular regeneration and hematopoietic reconstitution.
Termini CM; Pang A; Fang T; Roos M; Chang VY; Zhang Y; Setiawan NJ; Signaevskaia L; Li M; Kim MM; Tabibi O; Lin PK; Sasine JP; Chatterjee A; Murali R; Himburg HA; Chute JP
Nat Commun; 2021 Nov; 12(1):6990. PubMed ID: 34848712
[TBL] [Abstract][Full Text] [Related]
7. The Neuropilin-1 Ligand, Sema3A, Acts as a Tumor Suppressor in the Pathogenesis of Acute Leukemia.
Yang ZG; Wen RT; Qi K; Li J; Zheng GX; Wang YF; Hong YG; Zhang YM
Anat Rec (Hoboken); 2019 Jul; 302(7):1127-1135. PubMed ID: 30378769
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of the semaphorin 3A pathway in prostatic cancer.
Yacoub M; Coulon A; Celhay O; Irani J; Cussenot O; Fromont G
Histopathology; 2009 Oct; 55(4):392-8. PubMed ID: 19817889
[TBL] [Abstract][Full Text] [Related]
9. Increased ratio of vascular endothelial growth factor to semaphorin3A is a negative prognostic factor in human meningiomas.
Barresi V; Tuccari G
Neuropathology; 2010 Oct; 30(5):537-46. PubMed ID: 20337947
[TBL] [Abstract][Full Text] [Related]
10. Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis.
Guttmann-Raviv N; Shraga-Heled N; Varshavsky A; Guimaraes-Sternberg C; Kessler O; Neufeld G
J Biol Chem; 2007 Sep; 282(36):26294-305. PubMed ID: 17569671
[TBL] [Abstract][Full Text] [Related]
11. Semaphorin 3A lytic hybrid peptide binding to neuropilin-1 as a novel anti-cancer agent in pancreatic cancer.
Ueyama H; Horibe T; Nakajima O; Ohara K; Kohno M; Kawakami K
Biochem Biophys Res Commun; 2011 Oct; 414(1):60-6. PubMed ID: 21945444
[TBL] [Abstract][Full Text] [Related]
12. De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes.
Lopes MR; Pereira JK; de Melo Campos P; Machado-Neto JA; Traina F; Saad ST; Favaro P
Sci Rep; 2017 Jan; 7():40707. PubMed ID: 28084439
[TBL] [Abstract][Full Text] [Related]
13. Soluble Neuropilin-1 Response to Hypoglycemia in Type 2 Diabetes: Increased Risk or Protection in SARS-CoV-2 Infection?
Moin ASM; Al-Qaissi A; Sathyapalan T; Atkin SL; Butler AE
Front Endocrinol (Lausanne); 2021; 12():665134. PubMed ID: 34248841
[TBL] [Abstract][Full Text] [Related]
14. Neuropilin-1 Acts as a Receptor for Complement Split Products.
Battin C; De Sousa Linhares A; Paster W; Isenman DE; Wahrmann M; Leitner J; Zlabinger GJ; Steinberger P; Hofer J
Front Immunol; 2019; 10():2209. PubMed ID: 31572401
[TBL] [Abstract][Full Text] [Related]
15. Endothelial cell-derived semaphorin 3A inhibits filopodia formation by blood vascular tip cells.
Ochsenbein AM; Karaman S; Proulx ST; Berchtold M; Jurisic G; Stoeckli ET; Detmar M
Development; 2016 Feb; 143(4):589-94. PubMed ID: 26884395
[TBL] [Abstract][Full Text] [Related]
16. Neuropilin-1 mediates vascular permeability independently of vascular endothelial growth factor receptor-2 activation.
Roth L; Prahst C; Ruckdeschel T; Savant S; Weström S; Fantin A; Riedel M; Héroult M; Ruhrberg C; Augustin HG
Sci Signal; 2016 Apr; 9(425):ra42. PubMed ID: 27117252
[TBL] [Abstract][Full Text] [Related]
17. Selective requirements for NRP1 ligands during neurovascular patterning.
Vieira JM; Schwarz Q; Ruhrberg C
Development; 2007 May; 134(10):1833-43. PubMed ID: 17428830
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Konjac Ceramide (kCer) Binding to Sema3A Receptor Nrp1.
Usuki S; Tamura N; Tamura T; Mukai K; Igarashi Y
J Oleo Sci; 2018 Jan; 67(1):87-94. PubMed ID: 29238029
[TBL] [Abstract][Full Text] [Related]
19. The influence of neuropilin-1 silencing on semaphorin 3A and 3C activity in B16(F10) murine melanoma cells.
Mazurek AM; Olbryt M
Neoplasma; 2012; 59(1):43-51. PubMed ID: 22082309
[TBL] [Abstract][Full Text] [Related]
20. Expression changes and roles of Sema3A and Nrp1 in cultured rat cortical neurons after oxygen glucose deprivation.
He Y; Yang Y; Wang R; Wang H; Ma Q; Chen S; Shi D
Cell Mol Biol (Noisy-le-grand); 2018 Jun; 64(9):64-69. PubMed ID: 30030955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
